chr17-66878981-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_145811.3(CACNG5):c.206G>A(p.Arg69Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000763 in 1,612,402 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145811.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNG5 | NM_145811.3 | c.206G>A | p.Arg69Gln | missense_variant | 3/6 | ENST00000533854.6 | NP_665810.1 | |
CACNG5 | NM_001371476.1 | c.206G>A | p.Arg69Gln | missense_variant | 3/5 | NP_001358405.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNG5 | ENST00000533854.6 | c.206G>A | p.Arg69Gln | missense_variant | 3/6 | 2 | NM_145811.3 | ENSP00000436836 | P1 | |
CACNG5 | ENST00000307139.4 | c.206G>A | p.Arg69Gln | missense_variant | 2/5 | 1 | ENSP00000303092 | P1 | ||
CACNG5 | ENST00000673855.1 | c.206G>A | p.Arg69Gln | missense_variant | 2/4 | ENSP00000501267 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152142Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250756Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135508
GnomAD4 exome AF: 0.0000788 AC: 115AN: 1460260Hom.: 0 Cov.: 30 AF XY: 0.0000757 AC XY: 55AN XY: 726484
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152142Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2022 | The c.206G>A (p.R69Q) alteration is located in exon 2 (coding exon 2) of the CACNG5 gene. This alteration results from a G to A substitution at nucleotide position 206, causing the arginine (R) at amino acid position 69 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at